ENERGI-F703

N/A

Report date: 2023/07/07 20:01:23
NME

Base Information

Drug NameENERGI-F703
Drug Alias NameENERGI-F703ENERGIF-703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsWounds and InjuriesDiabetes MellitusFoot Ulcer +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnergenesis Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEnergenesis Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesDiabetes MellitusFoot Ulcer +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A